News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
483,255 Results
Type
Article (26394)
Company Profile (87)
Press Release (456765)
Multimedia
Podcasts (82)
Webinars (4)
Section
Business (130887)
Career Advice (1448)
Deals (24432)
Drug Delivery (99)
Drug Development (66686)
Employer Resources (63)
FDA (11602)
Job Trends (10076)
News (233602)
Policy (20409)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (1856)
Academic (1)
Accelerated approval (27)
Adcomms (16)
Allergies (117)
Alliances (29028)
ALS (145)
Alzheimer's disease (1391)
Antibody-drug conjugate (ADC) (288)
Approvals (11918)
Artificial intelligence (423)
Autoimmune disease (134)
Automation (30)
Bankruptcy (194)
Best Places to Work (8358)
BIOSECURE Act (17)
Biosimilars (169)
Biotechnology (50)
Bladder cancer (152)
Brain cancer (55)
Breast cancer (605)
Cancer (4535)
Cardiovascular disease (359)
Career advice (1168)
Career pathing (24)
CAR-T (241)
CDC (27)
Celiac Disease (1)
Cell therapy (636)
Cervical cancer (34)
Clinical research (58491)
Collaboration (1438)
Company closure (2)
Compensation (892)
Complete response letters (47)
COVID-19 (2054)
CRISPR (74)
C-suite (663)
Cystic fibrosis (140)
Data (5796)
Decentralized trials (1)
Denatured (10)
Depression (108)
Diabetes (507)
Diagnostics (4804)
Digital health (29)
Diversity (7)
Diversity, equity & inclusion (12)
Drug discovery (192)
Drug pricing (139)
Drug shortages (27)
Duchenne muscular dystrophy (179)
Earnings (68698)
Editorial (45)
Employer branding (11)
Employer resources (58)
Events (74788)
Executive appointments (786)
FDA (14364)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (9)
Frontotemporal dementia (20)
Funding (1250)
Gene editing (165)
Generative AI (36)
Gene therapy (502)
GLP-1 (1090)
Government (3131)
Grass and pollen (4)
Guidances (373)
Healthcare (13390)
HIV (58)
Huntington's disease (40)
IgA nephropathy (80)
Immunology and inflammation (238)
Immuno-oncology (58)
Indications (98)
Infectious disease (2289)
Inflammatory bowel disease (176)
Inflation Reduction Act (12)
Influenza (105)
Intellectual property (191)
Interviews (262)
IPO (13263)
IRA (28)
Job creations (2086)
Job search strategy (988)
JPM (53)
Kidney cancer (17)
Labor market (72)
Layoffs (400)
Leadership (28)
Legal (4066)
Liver cancer (86)
Longevity (13)
Lung cancer (626)
Lymphoma (361)
Machine learning (32)
Management (19)
Manufacturing (611)
MASH (162)
Medical device (9183)
Medtech (9220)
Mergers & acquisitions (12158)
Metabolic disorders (1323)
Multiple sclerosis (155)
NASH (20)
Neurodegenerative disease (283)
Neuropsychiatric disorders (79)
Neuroscience (2499)
Neurotech (1)
NextGen: Class of 2026 (4121)
Non-profit (3792)
Now hiring (26)
Obesity (647)
Opinion (182)
Ovarian cancer (151)
Pain (172)
Pancreatic cancer (203)
Parkinson's disease (272)
Partnered (23)
Patents (366)
Patient recruitment (428)
Peanut (52)
People (32330)
Pharmaceutical (27)
Pharmacy benefit managers (14)
Phase 1 (19810)
Phase 2 (25085)
Phase 3 (18891)
Pipeline (4692)
Policy (182)
Postmarket research (1857)
Preclinical (6766)
Press Release (34)
Prostate cancer (228)
Psychedelics (34)
Radiopharmaceuticals (251)
Rare diseases (737)
Real estate (3173)
Recruiting (30)
Regulatory (16881)
Reports (38)
Research institute (1783)
Resumes & cover letters (268)
Rett syndrome (27)
RNA editing (14)
RSV (66)
Schizophrenia (143)
Series A (195)
Series B (157)
Service/supplier (4)
Sickle cell disease (84)
Special edition (23)
Spinal muscular atrophy (159)
Sponsored (31)
Startups (2115)
State (1)
Stomach cancer (15)
Supply chain (89)
Tariffs (64)
The Weekly (71)
Vaccines (824)
Venture capital (58)
Weight loss (445)
Women's health (66)
Worklife (12)
Date
Today (14)
Last 7 days (515)
Last 30 days (1915)
Last 365 days (26245)
2026 (2424)
2025 (26580)
2024 (28538)
2023 (30849)
2022 (39749)
2021 (41673)
2020 (38642)
2019 (31945)
2018 (24418)
2017 (22944)
2016 (20558)
2015 (24100)
2014 (17164)
2013 (13415)
2012 (14065)
2011 (14685)
2010 (13546)
Location
Africa (537)
Alabama (70)
Alaska (4)
Arizona (172)
Arkansas (8)
Asia (29725)
Australia (5040)
California (9425)
Canada (2768)
China (1006)
Colorado (364)
Connecticut (425)
Delaware (285)
Europe (67679)
Florida (1295)
Georgia (305)
Hawaii (3)
Idaho (36)
Illinois (709)
India (54)
Indiana (402)
Iowa (17)
Japan (393)
Kansas (83)
Kentucky (35)
Louisiana (25)
Maine (53)
Maryland (1123)
Massachusetts (6919)
Michigan (261)
Minnesota (466)
Mississippi (6)
Missouri (103)
Montana (24)
Nebraska (13)
Nevada (104)
New Hampshire (67)
New Jersey (2583)
New Mexico (16)
New York (2497)
North Carolina (1192)
North Dakota (4)
Northern California (4572)
Ohio (252)
Oklahoma (13)
Oregon (32)
Pennsylvania (1768)
Puerto Rico (21)
Rhode Island (29)
South America (765)
South Carolina (47)
South Dakota (1)
Southern California (3756)
Tennessee (141)
Texas (1403)
United States (32980)
Utah (249)
Vermont (1)
Virginia (200)
Washington D.C. (61)
Washington State (751)
West Virginia (4)
Wisconsin (106)
Wyoming (1)
483,255 Results for "alpha 1 foundation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Insights
Biotech’s New Cycle, JPM Deal Hype and Where Alpha Still Hides
In this episode of Denatured, Jennifer C. Smith-Parker speaks with RTW’s Rod Wong and Stephanie Sirota how shifting JPM deal timing masks record M&A potential; why oncology, obesity, psychedelics, and neuroscience are attracting fresh capital; and how “alpha stacking” shapes their investment edge in an age of chronic uncertainty. They cover topics discussed in RTW’s new book, “Innovation is the Best Medicine.”
January 29, 2026
·
1 min read
·
Jennifer Smith-Parker
Press Releases
Wave Life Sciences Announces Plans to Accelerate Regulatory Engagement with Full Control of WVE-006 for Alpha-1 Antitrypsin Deficiency
February 2, 2026
·
7 min read
Press Releases
Alpha-9 Oncology Announces First Patient Dosed in Phase 1 Study of A9-3408 for the Treatment of Melanoma
December 4, 2025
·
3 min read
Press Releases
Alpha Tau Submits First Pre-Market Approval Module to the FDA for Alpha DaRT® for the Treatment of Recurrent Cutaneous Squamous Cell Carcinoma (cSCC)
January 5, 2026
·
5 min read
Press Releases
Press Release: Sanofi’s efdoralprin alfa earns orphan designation in the EU for alpha-1 antitrypsin deficiency related emphysema
December 17, 2025
·
6 min read
Press Releases
Kraig Biocraft Laboratories Successfully Completes Production Cycle, Delivering Over One Million BAM-1 Alpha Hybrid Eggs for Deployment
December 15, 2025
·
3 min read
Insights
Biotech’s Next Chapter: Asset-Centric Deals and Shifting Alpha at JPM 2026
After years of contraction, investors see biotech reentering a growth cycle driven by scientific progress, asset quality and renewed conviction in oncology, obesity and neuroscience innovation.
January 29, 2026
·
3 min read
·
Jennifer Smith-Parker
Press Releases
Alpha Tau Announces Presentation of Two Alpha DaRT Pancreatic Cancer Abstracts at Upcoming 2026 ASCO GI Symposium
December 5, 2025
·
5 min read
Press Releases
Regeneron and Tessera Therapeutics to Jointly Develop TSRA-196, an Investigational Gene Editing Therapy for Alpha-1 Antitrypsin Deficiency (AATD)
December 2, 2025
·
12 min read
Press Releases
Alpha Tau to Participate in December 2025 Investor Conferences
December 2, 2025
·
1 min read
1 of 48,326
Next
